12/2
07:33 am
goss
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio [Yahoo! Finance]
Low
Report
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio [Yahoo! Finance]
11/21
01:30 pm
goss
All You Need to Know About Gossamer Bio (GOSS) Rating Upgrade to Buy [Yahoo! Finance]
Medium
Report
All You Need to Know About Gossamer Bio (GOSS) Rating Upgrade to Buy [Yahoo! Finance]
11/14
11:31 am
goss
After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS) [Yahoo! Finance]
Medium
Report
After Plunging -15.92% in 4 Weeks, Here's Why the Trend Might Reverse for Gossamer Bio (GOSS) [Yahoo! Finance]
11/12
07:02 am
goss
Industry Analysts Just Made A Sizeable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Revenue Forecasts [Yahoo! Finance]
Medium
Report
Industry Analysts Just Made A Sizeable Upgrade To Their Gossamer Bio, Inc. (NASDAQ:GOSS) Revenue Forecasts [Yahoo! Finance]
11/11
04:01 pm
goss
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11/11
10:22 am
goss
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Low
Report
Gossamer Bio, Inc. (NASDAQ: GOSS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
11/10
07:33 am
goss
Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets [Yahoo! Finance]
Low
Report
Gossamer Bio, Inc. (NASDAQ:GOSS) Just Reported And Analysts Have Been Lifting Their Price Targets [Yahoo! Finance]
11/7
05:28 pm
goss
Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
11/7
04:03 pm
goss
Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
Low
Report
Gossamer Bio Announces Third Quarter 2024 Financial Results and Provides Business Update
10/7
05:01 pm
goss
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/3
08:49 am
goss
Several Insiders Invested In Gossamer Bio Flagging Positive News [Yahoo! Finance]
Medium
Report
Several Insiders Invested In Gossamer Bio Flagging Positive News [Yahoo! Finance]